The hepatitis B virus transactivator HBx causes elevation of diacylglycerol and activation of protein kinase C

Aaronson, 1968, Basis for the acquisition of malignant potential by mouse cells cutivated in vitro, Science, 162, 1024, 10.1126/science.162.3857.1024 Angel, 1991, The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation, Biochim. Biophys. Acta (Amst), 1072, 129 Baniahmad, 1990, Modular structure of a chicken lysozyme silencer: involvement of an unusual thyroid hormone receptor binding site, Cell, 61, 505, 10.1016/0092-8674(90)90532-J Beasley, 1981, Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan, Lancet, 1129, 10.1016/S0140-6736(81)90585-7 Billah, 1990, Review article: The regulation and cellular functions of phosphatidylcholine hydrolysis, Biochem. J., 269, 281, 10.1042/bj2690281 Chang, 1954, Continuous subcultivation of epithelial-like cells from normal human tissues, Proc. Soc. Exp. Biol., 87, 440, 10.3181/00379727-87-21406 Dejean, 1986, Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma, Nature (Lond.), 322, 70, 10.1038/322070a0 Gorman, 1982, Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells, Mol. Cell. Biol., 2, 1044, 10.1128/MCB.2.9.1044 Graham, 1973, A new technique for the assay of infectivity of human adenovirus 5 DNA, Virology, 52, 456, 10.1016/0042-6822(73)90341-3 Haliotis, 1990, Expression of ras oncogene leads to downregulation of protein kinase C, Int. J. Cancer, 45, 1177, 10.1002/ijc.2910450631 Hannun, 1986, Shingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets, J. Biol. Chem., 261, 12604, 10.1016/S0021-9258(18)67133-9 Hidaka, 1984, Isoquinoline sulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase, C. Biochemistry, 23, 5036, 10.1021/bi00316a032 Höhne, 1990, Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA, EMBO J., 9, 1137, 10.1002/j.1460-2075.1990.tb08220.x Hoffmann, 1989, Proliferation of fetal rat hepatocytes in response to growth factors and hormones in primary culture, J. Cell. Physiol., 139, 654, 10.1002/jcp.1041390328 Kekulé, 1993, Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway, Nature (Lond.), 361, 742, 10.1038/361742a0 Kim, 1991, HBx gene of hepatitis B virus induces liver cancer in transgenic mice, Nature (Lond.), 351, 317, 10.1038/351317a0 Lee, 1990, Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice, J. Virol., 64, 5939, 10.1128/JVI.64.12.5939-5947.1990 Loomis, 1988, Sangivamycin, a nucleoside analogue, is a potent inhibitor of protein kinase C, J. Biol. Chem., 263, 1682, 10.1016/S0021-9258(19)77930-7 Maguire, 1991, HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions, Science, 252, 842, 10.1126/science.1827531 Maly, 1989, Ha-ras activates the Na+/H+ antiporter by a protein kinase C-independent mechanism, J. Biol. Chem., 264, 11839, 10.1016/S0021-9258(18)80142-9 Megidish, 1989, A mutant protein kinase C that can transform fibroblasts, Nature (Lond.), 342, 807, 10.1038/342807a0 Nishizuka, 1984, The role of protein kinase C in cell surface signal transduction and tumour promotion, Nature (Lond.), 308, 693, 10.1038/308693a0 Piccoletti, 1990, Activity and distribution of protein kinase C in liver during the acute-phase response, Biochem. Biophys. Res. Commun., 167, 345, 10.1016/0006-291X(90)91771-J Preiss, 1986, Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells, J. Biol. Chem., 261, 8597, 10.1016/S0021-9258(19)84420-4 Rossner, 1992, Review: Hepatitis B virus X-gene product: A promiscuous transcriptional activator, J. Med. Virol., 36, 101, 10.1002/jmv.1890360207 Schütte, 1989, Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms Rat-1a cells as a single gene, 86, 2257 Seifer, 1991, In vitro tumorigenicity of hepatitis B virus DNA and HBx protein, J. Hepatology, 13, S61, 10.1016/0168-8278(91)90026-8 Seto, 1990, Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors, Nature (Lond.), 344, 72, 10.1038/344072a0 Shirakata, 1989, The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells, Jap. J. Cancer Res., 80, 617, 10.1111/j.1349-7006.1989.tb01686.x Spandau, 1988, Trans-activation of viral enhancers by the hepatitis B virus X protein, J. Virol., 62, 427, 10.1128/JVI.62.2.427-434.1988 Twu, 1987, Transcriptional trans-activating function of hepatitis B virus, J. Virol., 61, 3448, 10.1128/JVI.61.11.3448-3453.1987 Unger, 1990, The X protein of the hepatitis V virus acts as a transcription factor when targeted to its responsive element, EMBO J., 9, 1889, 10.1002/j.1460-2075.1990.tb08315.x Van Veldhoven, 1988, Effect of harvesting methods, growth conditions and growth phase on diacylglycerol levels in cultured human adherent cells, Biochem. Biophys. Acta (Amst.), 959, 185, 10.1016/0005-2760(88)90030-6 Wang, 1990, Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma, Nature (Lond.), 343, 555, 10.1038/343555a0 Wolfman, 1987, Elevated levels of diacylglycerol and decreased phorol ester sensitivity in ras-transformed fibroblasts, Nature (Lond.), 325, 359, 10.1038/325359a0 Wollersheim, 1988, A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state, Oncogene, 3, 545 Wu, 1990, The hepatitis B virus-encoded transcriptional Trans-activator hbx appears to be a novel protein serine/threonine kinase, Cell, 63, 687, 10.1016/0092-8674(90)90135-2 Young, 1987, Downregulation of protein kinase C is due to an increased rate of degradation, Biochem. J., 244, 775, 10.1042/bj2440775 Zahm, 1988, The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis, Oncogene, 3, 169